Evidence map›Paper›PMID 32820876›Full record

ArticleJournal of clinical research in pediatric endocrinology2021

Genotype and Phenotype Heterogeneity in Neonatal Diabetes: A Single Centre Experience in Turkey

Yasemin Denkboy Öngen, Erdal Eren, Özgecan Demirbaş, Elif Sobu, Sian Ellard, Elisa De Franco, Ömer Tarım

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical research in pediatric endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Neonatal diabetes mellitus around the world: Update 2024.Journal of diabetes investigation · 2024
    Review
  3. A New Variant of theJournal of clinical research in pediatric endocrinology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yasemin Denkboy ÖngenBursa Uludağ University Faculty of Medicine, Department of Pediatric Endocrinology, Bursa, TurkeyORCID 0000-0002-5657-4260
Erdal ErenBursa Uludağ University Faculty of Medicine, Department of Pediatric Endocrinology, Bursa, TurkeyORCID 0000-0002-1684-1053
Özgecan DemirbaşBursa Uludağ University Faculty of Medicine, Department of Pediatric Endocrinology, Bursa, TurkeyORCID 0000-0002-6922-5203
Elif SobuBursa Uludağ University Faculty of Medicine, Department of Pediatric Endocrinology, Bursa, TurkeyORCID 0000-0002-2037-7046
Sian EllardUniversity of Exeter Medical School, Institute of Biomedical and Clinical Science, Exeter, United KingdomORCID 0000-0002-7620-5526
Elisa De FrancoUniversity of Exeter Medical School, Institute of Biomedical and Clinical Science, Exeter, United KingdomORCID 0000-0002-1437-7891
Ömer TarımBursa Uludağ University Faculty of Medicine, Department of Pediatric Endocrinology, Bursa, TurkeyORCID 0000-0002-5322-5508
Bursa Uludağ Üni̇versi̇tesi̇ · TRUniversity of Exeter · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

Objective: Neonatal diabetes mellitus (NDM) may be transient or permanent, and the majority is caused by genetic mutations. Early diagnosis is essential to select the patients who will respond to oral treatment. In this investigation, we aimed to present the phenotype and genotype of our patients with NDM and share our experience in a single tertiary center Methods: A total of 16 NDM patients from 12 unrelated families are included in the study. The clinical presentation, age at diagnosis, perinatal and family history, consanguinity, gender, hemoglobin A1c, C-peptide, insulin, insulin autoantibodies, genetic mutations, and response to treatment are retrospectively evaluated. Results: The median age at diagnosis of diabetes was five months (4 days-18 months) although six patients with a confirmed genetic diagnosis were diagnosed >6 months. Three patients had Conclusion: Although NDM is defined as diabetes diagnosed during the first six months of life, and a diagnosis of type 1 diabetes is more common between the ages of 6 and 24 months, in rare cases NDM may present as late as 12 or even 24 months of age. Molecular diagnosis in NDM is important for planning treatment and predicting prognosis. Therefore, genetic testing is essential in these patients.

Indexed as

Diabetes MellitusDiabetes Mellitus, Type 1FemaleGenotypeHumansInfantInfant, NewbornInfant, Newborn, DiseasesMalePhenotypeSyndromegeneticmonogenic diabetesNeonatal diabetespotassium channelsulfonylureasyndromic neonatal diabetes

Identifiers

PMID32820876
PMCPMC7947723
OpenAlexW3080436002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.